A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
Clinical trial NCT05656092 · COMPLETED
Trial details
- NCT number
- NCT05656092
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2024-12-19
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.